Insider Selling: Tristel plc (LON:TSTL) Insider Sells 50,000 Shares of Stock

Tristel plc (LON:TSTL) insider Paul Christopher Swinney sold 50,000 shares of the firm’s stock in a transaction dated Tuesday, April 16th. The stock was sold at an average price of GBX 462 ($5.75), for a total transaction of £231,000 ($287,563.80).

Tristel Trading Down 0.6 %

TSTL stock opened at GBX 467.30 ($5.82) on Wednesday. The company has a market capitalization of £221.92 million, a PE ratio of 3,615.38 and a beta of 0.28. Tristel plc has a 12 month low of GBX 315 ($3.92) and a 12 month high of GBX 503.50 ($6.27). The firm’s 50-day moving average is GBX 460.06 and its 200 day moving average is GBX 440.17. The company has a debt-to-equity ratio of 19.12, a current ratio of 4.92 and a quick ratio of 3.83.

Tristel Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, April 12th. Investors of record on Thursday, March 21st were paid a GBX 5.24 ($0.07) dividend. This represents a yield of 1.16%. The ex-dividend date was Thursday, March 21st. Tristel’s dividend payout ratio is presently 10,000.00%.

Tristel Company Profile

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.